Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT03531918 |
| Title | Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine and Mitoxantrone in Treating Participants With Previously Untreated Acute Myeloid Leukemia or High-Grade Myeloid Neoplasm |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Fred Hutchinson Cancer Research Center |
| Indications | |
| Therapies |
Cladribine + Cytarabine + Filgrastim + Gemtuzumab ozogamicin + Mitoxantrone |
| Age Groups: | adult | senior |
| Covered Countries | USA |